(Q47644014)

4 February 2018

title

Direct-Acting Antiviral Sustained Virologic Response: Impact on Mortality in Patients without Advanced Liver Disease. (English)

1 reference

4 February 2018

0 references

Lisa I Backus

1

1 reference

4 February 2018

Pamela S Belperio

series ordinal

2

1 reference

4 February 2018

Troy A Shahoumian

series ordinal

3

1 reference

4 February 2018

Larry A Mole

series ordinal

4

1 reference

4 February 2018

language of work or name

English

0 references

publication date

29 January 2018

1 reference

4 February 2018

published in

Hepatology

1 reference

4 February 2018

Reversion of disease manifestations after HCV eradication

cites work

1 reference

7 January 2021

Management of the patient with SVR.

1 reference

7 January 2021

Effectiveness of Sofosbuvir, Ledipasvir/Sofosbuvir, or Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir Regimens for Treatment of Patients With Hepatitis C in the Veterans Affairs National Health Care System

1 reference

7 January 2021

Comparative effectiveness of ledipasvir/sofosbuvir ± ribavirin vs. ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in 6961 genotype 1 patients treated in routine medical practice.

1 reference

7 January 2021

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

1 reference

7 January 2021

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

1 reference

7 January 2021

ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.

1 reference

7 January 2021

ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis

1 reference

7 January 2021

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

1 reference

7 January 2021

Effectiveness of sofosbuvir-based regimens in genotype 1 and 2 hepatitis C virus infection in 4026 U.S. Veterans.

1 reference

7 January 2021

Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

1 reference

7 January 2021

A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.

1 reference

7 January 2021

Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial.

1 reference

7 January 2021

Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon

1 reference

7 January 2021

American Gastroenterological Association Institute Clinical Practice Update-Expert Review: Care of Patients Who Have Achieved a Sustained Virologic Response After Antiviral Therapy for Chronic Hepatitis C Infection

1 reference

7 January 2021

Restricted Access: State Medicaid Coverage of Sofosbuvir Hepatitis C Treatment

1 reference

7 January 2021

Transformation of hepatitis C antiviral treatment in a national healthcare system following the introduction of direct antiviral agents.

1 reference

7 January 2021

Curing Hepatitis C Virus Infection: Best Practices From the U.S. Department of Veterans Affairs

1 reference

7 January 2021

Clinical Case Registries: simultaneous local and national disease registries for population quality management

1 reference

7 January 2021

A new equation to estimate glomerular filtration rate

1 reference

7 January 2021

P0714 : Impact of prioritizing treatment in a high resource setting - minimizing the burden of HCV related disease in 15 years

1 reference

7 January 2021

Impact of Sustained Virologic Response with Direct-Acting Antiviral Treatment on Mortality in Patients with Advanced Liver Disease

1 reference

7 January 2021

Interferon-Free Therapy in Elderly Patients With Advanced Liver Disease

1 reference

7 January 2021

Hepatitis B, hepatitis C and mortality among HIV-positive individuals

1 reference

7 January 2021

Engagement in Care of High-Risk Hepatitis C Patients with Interferon-Free Direct-Acting Antiviral Therapies

1 reference

7 January 2021

Extrahepatic manifestations of chronic hepatitis C virus infection.

1 reference

7 January 2021

Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations

1 reference

7 January 2021

Systemic inflammation predicts all-cause mortality: a glasgow inflammation outcome study.

1 reference

7 January 2021

Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly

1 reference

7 January 2021

What is the impact of chronic systemic inflammation such as rheumatoid arthritis on mortality following cancer?

1 reference

7 January 2021

The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.29811

1 reference

4 February 2018

PubMed ID

29377196

1 reference

4 February 2018